Matthew W. Strobeck

Chief Investment Officer & Managing Partner at Birchview Capital LP

Matthew W. Strobeck

Matthew W. Strobeck

Chief Investment Officer & Managing Partner at Birchview Capital LP

Overview
Career Highlights

Birchview Capital LP

RelSci Relationships

278

Number of Boards

11

Birthday

1973

Age

45

Relationships
RelSci Relationships are individuals Matthew W. Strobeck likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at Monteris Medical US, Inc.

Relationship likelihood: Strong

Co-Director of the Malaysia-MIT Biotechnology Partnership Program at Massachusetts Institute of Technology

Relationship likelihood: Strong

Co-Founder at Crabtree Partners LLC

Relationship likelihood: Strong

Advisory Director at Sit Investment Associates, Inc.

Relationship likelihood: Strong

General Partner at The Vertical Group LP

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Accelerate Diagnostics, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at Biodesix, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Tepha, Inc.

Relationship likelihood: Strong

Chief Technology Officer at Biodesix, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Global Kinetics Corp. Ltd.

Relationship likelihood: Strong

Paths to Matthew W. Strobeck
Potential Connections via
Relationship Science
You
Matthew W. Strobeck
Chief Investment Officer & Managing Partner at Birchview Capital LP
Education
Ph.D. in Cellular & Molecular Biology
Class of 2001

University of Cincinnati is a comprehensive public research university in Cincinnati, in the U.S. state of Ohio, and a part of the University System of Ohio. Founded in 1819 as Cincinnati College, it is the oldest institution of higher education in Cincinnati and has an annual enrollment of over 40,000 students, making it the second largest university in Ohio and one of the largest universities in the United States.

B.S.
Class of 1996

St. Lawrence University was founded in 1856 as a coeducational institution and remains the oldest continuously coeducational college in New York State. The mission of St. Lawrence University is to provide an inspiring and demanding undergraduate education in the liberal arts to students selected for their seriousness of purpose and intellectual promise.

S.M.

MIT Sloan School of Management is the business school of the Massachusetts Institute of Technology, in Cambridge, Massachusetts, USA. MIT Sloan offers bachelor's, master's, and doctoral programs, as well as non-degree executive education. Its largest program is its full-time MBA, which is one of the most selective in the world, with students from more than 60 countries every year, and ranked #1 in more subjects than any other MBA program.

SM University-MIT Health Sciences Technology Program

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Career History
Chief Investment Officer & Managing Partner
2014 - Current

Birchview Capital LP is an American private company located in Burlington, VT, with domestic subsidiaries. The firm provides investment advice. It was founded in 2014 by Matthew William Strobeck, who has been the CEO since that date.

Independent Director, Member, Audit Committee
Current

Yield10 Bioscience, Inc. is an agricultural bioscience company, which focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.

Partner
2003 - 2011

Westfield Capital Management (WCM) is a growth manager that seeks to invest in the reasonably priced stocks of companies with high earnings potential. The firm uses fundamental, bottom-up research to identify growth companies across all market-caps. They seek to identify companies capable of providing consistently high or accelerating earnings growth. WMC supervises mainly investments in publicly traded, domestic growth equities, with investment products focusing on each segment of the capitalization spectrum. The firm also supervises investments in foreign equities that are traded on US stock exchanges and in US dollars, American Depositary Receipts (ADRs), American Depositary Shares (ADS), and Global Depositary Receipts (GDRs).WMC's investment strategies include: Large Cap Growth, Small/Mid Cap Growth, Mid Cap Growth, All Cap Growth, Dividend Growth, Sustainable Growth, Micro Cap, and Select Growth Equity. The following strategies are closed to new investors: Small Cap Growth, Fixed Income, and Life Sciences.With the exception of their Mid Cap Strategy, WMC does not generally invest in derivatives, options, or privately held securities, and does not permit short selling. The Micro-Cap Strategy permits the usage of leveraging techniques, short selling, frequent trading, investments in private securities, and investments in derivatives or options. As such, the Micro-Cap Strategy will enter into a short position in a broad market index ETF. Under normal market conditions, the firm's long-only equity products don't use a frequent trading strategy; however, in certain market conditions, trading activity within products may increase.

Boards & Committees
Member, Board of Directors
2018 - Current

Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of diagnostic healthcare solutions serving to enhance the health and well being of people around the globe with well known and respected products that provide healthcare professionals with accurate and cost-effective diagnostic information at the point of care (POC).

Member, Board of Directors
2014 - Current

Monteris Medical, Inc. operates as a medical device company that develops laser-based systems to treat brain tumors. It offers the AXiiiS Stereotactic Miniframe, a single use platform for image-guided, stereotactic brain biopsy, and the AtamA Stabilization System for MRI-guided neurosurgical procedures that require rigid head fixation. The company was founded by Mark G. Torchia in 1999 and is headquartered in Winnipeg, Canada.

Member, Board of Directors
2012 - Current

Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$10K - $25K
2009

City Year is an American education nonprofit organization founded in 1988 dedicated to helping students and schools succeed. The organization partners with public schools in 29 high-need communities across the US and through international affiliates in the UK and Johannesburg, South Africa. City Year teams are made up of 18 to 24 year olds, who provide student, classroom, and whole school support, intended to help students stay in school and on track to graduate high school. City Year is a member of the AmeriCorps national service network, and is supported by the Corporation for National and Community Service, school district partnerships, and private philanthropy from corporations, foundations and individuals.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Matthew W. Strobeck. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Matthew W. Strobeck's profile does not indicate a business or promotional relationship of any kind between RelSci and Matthew W. Strobeck.